Breaking News Instant updates and real-time market news.

AXON

Axovant Sciences

$22.07

-0.56 (-2.47%)

14:50
08/16/17
08/16
14:50
08/16/17
14:50

Axavont Sciences attracts a defensive option play

Axavont Sciences attracts a defensive option play. The stock down 63c to $22 and 3K Oct 10 - 15, 2X1, put spreads opened for 85c. The new position offers a max payout if shares tumble to $10 through the October expiration and is likely a play (or a hedge) on Phase 3 study results of an Alzheimer drug due late-September.

  • 18

    Aug

AXON Axovant Sciences
$22.07

-0.56 (-2.47%)

07/12/17
OPCO
07/12/17
NO CHANGE
OPCO
Outperform
Axovant Sciences upcoming results may drive valuation upside, says Oppenheimer
Oppenheimer analyst Jay Olson notes that Axovant Sciences faces two substantial binary events including the Phase 3 MINDSET study results at the end of September and the Phase 2 HEADWAY study results in Q4. The combination of these two events could drive up to 100% valuation upside, he contends. Further, the analyst believes the company is positioned to deliver the first new symptomatic Alzheimer's Disease drug approved by the FDA in over a decade. Olson reiterates an Outperform rating on the shares.
07/10/17
JEFF
07/10/17
INITIATION
Target $40
JEFF
Buy
Axovant Sciences initiated with a Buy at Jefferies
Jefferies analyst Michael Yee initiated Axovant Sciences with a Buy and a $40 price target.
06/14/17
OPCO
06/14/17
NO CHANGE
Target $30
OPCO
Outperform
Axovant Sciences price target raised to $30 from $26 at Oppenheimer
Oppenheimer analyst Jay Olson raised his price target for Axovant Sciences to $30 after leaving a meeting with management "incrementally more positive." The analyst is "encouraged" by management's vision which he says extends beyond dementia into other areas of high unmet need within neurology. He believes the focus on dementia with Lewy bodies and Lewy body dementia, which includes Parkinson's disease dementia, could "create significant value for shareholders." Olson sees a favorable risk/reward profile for intepirdine in the Phase 3 Mindset study with top-line results due in late September. He keeps an Outperform rating on Axovant.
04/17/17
JEFF
04/17/17
NO CHANGE
Target $31
JEFF
Buy
Jefferies sees Axovant shares hitting $5 or $90 on Sept. data
Jefferies analyst Biren Amin last week hosted investor meetings with Axovant Sciences' incoming CEO David Hung and Vivek Ramaswamy, who is transitioning to CEO of privately held Roivant. He notes the stock is up 45% since the announcement. "This is the stupidest thing I've ever heard," Hung said of the investor theory that he believes intepirdine will fail, Amin tells investors in a research note. It seems Axovant's profile fit what Hung was looking for and he conducted extensive due diligence on both intepirdine and nelotanserin, the analyst writes. He adds that the new CEO believes both products, in aggregate, offer five opportunities for value creation. Regarding the late September Phase III readout for intepirdine in mild to moderate Alzheimer's disease, Amin believes Axovant shares could trade to $80-$90 with strong improvement on the Alzheimer's disease assessment scale, or ADS-cog, of 1.5 point at 24 weeks and positive ADCS-adl, or Alzheimer's disease cooperative study - activities of daily living outcome. With a more moderate outcome where ADS-cog ranges between 0.7 and 1.3 point improvement and ADCS-adl does not achieve statistical significance, the analyst thinks the shares could still range higher to $45-$50. If the Mindset trial fails, he thinks the shares could drop to $5. Axovant closed Thursday up $2.20 to $22.

TODAY'S FREE FLY STORIES

FCAU

Fiat Chrysler

$17.96

0.59 (3.40%)

15:00
09/22/17
09/22
15:00
09/22/17
15:00
Options
$8.4M call buyer in Fiat Chrysler »

$8.4M call buyer in Fiat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$171.11

-1.06 (-0.62%)

14:53
09/22/17
09/22
14:53
09/22/17
14:53
Periodicals
Facebook settles lawsuit over non-voting shares, Business Insider reports »

Facebook settled a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

XOP

SPDR Oil Exploration and Production Fund

$33.00

0.09 (0.27%)

14:50
09/22/17
09/22
14:50
09/22/17
14:50
Options
SPDR Oil Exploration and Production ETF puts outpace calls 6:1 »

SPDR Oil Exploration and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTXI

GTx

$8.74

0.17 (1.98%)

14:48
09/22/17
09/22
14:48
09/22/17
14:48
Conference/Events
GTx, Inc to hold a KOL luncheon meeting »

Management hosts a KOL…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EXPE

Expedia

$143.12

0.11 (0.08%)

14:45
09/22/17
09/22
14:45
09/22/17
14:45
Options
Expedia call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$74.21

-7.54 (-9.22%)

14:35
09/22/17
09/22
14:35
09/22/17
14:35
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPPI

Spectrum

$9.81

-0.13 (-1.31%)

14:27
09/22/17
09/22
14:27
09/22/17
14:27
Hot Stocks
Spectrum lower after Twitter highlights failed trial in Korea »

Shares of Spectrum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

DLPH

Delphi

$102.58

1.54 (1.52%)

14:21
09/22/17
09/22
14:21
09/22/17
14:21
Conference/Events
Delphi to hold investor update meeting »

Investor Update Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

$NSD

NASDAQ Market Internals

14:17
09/22/17
09/22
14:17
09/22/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
09/22/17
09/22
14:16
09/22/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$117.03

0.56 (0.48%)

14:15
09/22/17
09/22
14:15
09/22/17
14:15
Options
Chevron put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 09

    Nov

S

Sprint

$8.42

0.39 (4.86%)

, TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

14:12
09/22/17
09/22
14:12
09/22/17
14:12
Periodicals
Sprint hired lobbyist tied to Trump in September, Reuters says »

Sprint (S) hired a…

S

Sprint

$8.42

0.39 (4.86%)

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 16

    May

OPK

OPKO Health

$6.48

0.15 (2.37%)

14:05
09/22/17
09/22
14:05
09/22/17
14:05
Options
Opko Health call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

14:05
09/22/17
09/22
14:05
09/22/17
14:05
General news
Dallas Fed hawk Kaplan is open minded about one more hike »

Dallas Fed hawk Kaplan is…

GWRE

Guidewire

$78.42

1.26 (1.63%)

14:04
09/22/17
09/22
14:04
09/22/17
14:04
Conference/Events
Guidewire to host analyst day »

Analyst Day to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCPT

Four Corners Property Trust

$25.05

-0.27 (-1.07%)

, WPG

Washington Prime

$8.13

0.095 (1.18%)

14:02
09/22/17
09/22
14:02
09/22/17
14:02
Recommendations
Four Corners Property Trust, Washington Prime analyst commentary  »

Four Corners Property…

FCPT

Four Corners Property Trust

$25.05

-0.27 (-1.07%)

WPG

Washington Prime

$8.13

0.095 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$61.75

-0.76 (-1.22%)

, UNH

UnitedHealth

$188.70

-6.51 (-3.33%)

14:02
09/22/17
09/22
14:02
09/22/17
14:02
Hot Stocks
Health insurers jump as McCain comes out against latest repeal/replace effort »

Shares of a number of…

MOH

Molina Healthcare

$61.75

-0.76 (-1.22%)

UNH

UnitedHealth

$188.70

-6.51 (-3.33%)

CNC

Centene

$87.58

-3.16 (-3.48%)

WCG

WellCare

$163.07

-2.99 (-1.80%)

CI

Cigna

$181.14

-0.99 (-0.54%)

ANTM

Anthem

$181.21

-2.29 (-1.25%)

HNT

Health Net

HUM

Humana

$235.79

-2.85 (-1.19%)

AET

Aetna

$150.76

-2.63 (-1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

ICPT

Intercept

$73.70

-24.42 (-24.89%)

13:57
09/22/17
09/22
13:57
09/22/17
13:57
Downgrade
Intercept rating change  »

Oppenheimer downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$46.29

0.87 (1.92%)

13:57
09/22/17
09/22
13:57
09/22/17
13:57
Hot Stocks
Trump thanks American Airlines for 'fantastic job' with hurricane flights »

President Donald Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

IWM

iShares Trust Russell 2000 Index Fund

$144.38

0.69 (0.48%)

, RUT

Russell 2000 Index

13:53
09/22/17
09/22
13:53
09/22/17
13:53
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT) is…

IWM

iShares Trust Russell 2000 Index Fund

$144.38

0.69 (0.48%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$61.77

-0.74 (-1.18%)

, UNH

UnitedHealth

$189.08

-6.13 (-3.14%)

13:53
09/22/17
09/22
13:53
09/22/17
13:53
Periodicals
McCain says cannot vote for Graham-Cassidy healthcare bill, Bloomberg reports »

Publicly traded companies…

MOH

Molina Healthcare

$61.77

-0.74 (-1.18%)

UNH

UnitedHealth

$189.08

-6.13 (-3.14%)

CNC

Centene

$87.61

-3.13 (-3.45%)

WCG

WellCare

$162.70

-3.36 (-2.02%)

CI

Cigna

$181.18

-0.9483 (-0.52%)

ANTM

Anthem

$181.24

-2.26 (-1.23%)

HNT

Health Net

HUM

Humana

$235.91

-2.735 (-1.15%)

AET

Aetna

$150.81

-2.58 (-1.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

XLE

Energy Select Sector SPDR

$67.08

0.22 (0.33%)

, XLI

Industrial Select Sector SPDR

$70.76

0.19 (0.27%)

13:51
09/22/17
09/22
13:51
09/22/17
13:51
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

For the week, the S&P…

XLE

Energy Select Sector SPDR

$67.08

0.22 (0.33%)

XLI

Industrial Select Sector SPDR

$70.76

0.19 (0.27%)

XLF

Financial Select Sector

$25.43

-0.035 (-0.14%)

XLB

S&P Select Materials SPDR

$56.57

-0.18 (-0.32%)

XLP

Consumer Staples Sector SPDR

$53.97

-0.115 (-0.21%)

XLU

Utilities SPDR

$53.43

-0.24 (-0.45%)

XLV

Health Care Select Sector SPDR

$81.25

-0.33 (-0.40%)

SPY

SPDR S&P 500 ETF Trust

$249.16

-0.23 (-0.09%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$54.07

0.16 (0.30%)

, UGI

UGI Corporation

$47.06

-0.28 (-0.59%)

13:50
09/22/17
09/22
13:50
09/22/17
13:50
Periodicals
Total sells Total Italia Gas to UGI Corporation, Reuters reports »

Total (TOT) has sold its…

TOT

Total

$54.07

0.16 (0.30%)

UGI

UGI Corporation

$47.06

-0.28 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$21.56

0.3975 (1.88%)

13:50
09/22/17
09/22
13:50
09/22/17
13:50
Options
One-week option play opened in Macy's »

One-week option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

ICPT

Intercept

13:48
09/22/17
09/22
13:48
09/22/17
13:48
Downgrade
Intercept rating change  »

Intercept downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.